Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01777945
Brief Title: XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

First Submitted : January 25, 2013
First Submitted that Met QC Criteria : January 25, 2013
First Posted : January 29, 2013 (Estimate)

Results First Submitted : April 12, 2016
Results First Submitted that Met QC Criteria : July 12, 2016
Results First Posted : August 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 12, 2016
Last Update Posted : August 19, 2016 (Estimate)